Olga Uspenskaya

Olga Uspenskaya

Company: Eli Lilly

Job title: Vice President - Clinical Development




Safety Monitoring Considerations in Early Phase AAV-based Gene Therapy Trials Targeting CNS Disorders 10:00 am

Signs of adverse events can arise during clinical trials, this presentation will provide a comprehensive overview of best practice for detecting, evaluating and monitoring safety signals in the clinic Including what to look for, how often to monitor safety signals observed and how to interpret the data Strategies to overcome unexpected safety data observed in…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.